Accessories to SIV Control: T Cell Vaccination Shows Potential

Accessories to SIV Control: T Cell Vaccination Shows Potential

Bibliographic Details
Main Authors:	Merlin L. Robb, Diane L. Bolton
Format:	Article
Language:	English
Published:	Elsevier 2017-04-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417301561

Similar Items

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication
by: Huanbin Xu, et al.
Published: (2017-04-01)

Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques.
by: Emily R Roberts, et al.
Published: (2016-12-01)

Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination
by: Eun-Ju Ko, et al.
Published: (2019-12-01)

Limelight on two HIV/SIV accessory proteins in macrophage infection: Is Vpx overshadowing Vpr?
by: Maudet Claire, et al.
Published: (2010-04-01)

VSV/MVA vaccine rapidly elicits SIV antibodies and local and systemic SIV T cell responses in macaque neonates but does not prevent SIV dissemination after oral challenge
by: Kozlowski Pamela, et al.
Published: (2008-04-01)

Fragmentation of SIV-gag vaccine induces broader T cell responses.
by: Adel Benlahrech, et al.
Published: (2012-01-01)

Expression of SIV antigens in live Salmonella vaccines
by: Strahan, Karen M.
Published: (1992)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
by: Hamimi C, et al.
Published: (2012-09-01)

Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
by: Sun C, et al.
Published: (2012-09-01)

Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
by: Melanie Schwerdtfeger, et al.
Published: (2019-05-01)

SIV proviral landscape differs from that of HIV-1 and shows gross hypermutation
by: A.J. Murray, et al.
Published: (2017-12-01)

Immunobiological Correlates of SIV Vaccine Vectors and Macaque Tropism
by: Joseph Antony
Published: (2019-12-01)

Combined single-cell quantitation of host and SIV genes and proteins ex vivo reveals host-pathogen interactions in individual cells.
by: Diane L Bolton, et al.
Published: (2017-06-01)

Single-cell transcriptome of in vivo SIV-infected rhesus macaque CD4 T cells
by: A. Tokarev, et al.
Published: (2019-12-01)

Mucosal SIV vaccines comprising inactivated virus particles and bacterial adjuvants induce CD8+T-regulatory cells that suppress SIV positive CD4+cell activation and prevent SIV infection in the macaque model.
by: Jean Marie eAndrieu, et al.
Published: (2014-06-01)

OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
by: Moss B, et al.
Published: (2009-10-01)

Evaluation of Functional NK Cell Responses in Vaccinated and SIV-Infected Rhesus Macaques
by: Diego A. Vargas-Inchaustegui, et al.
Published: (2016-08-01)

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
by: Jensen K, et al.
Published: (2012-09-01)

Rectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIVΔnef Vaccination.
by: Natalia Guerra-Pérez, et al.
Published: (2016-01-01)

Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.
by: Chie Sugimoto, et al.
Published: (2010-01-01)

P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
by: Turner SJ, et al.
Published: (2009-10-01)

Global Analysis of a Novel Nonlinear Stochastic SIVS Epidemic System with Vaccination Control
by: Xiaona Leng, et al.
Published: (2017-01-01)

Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs.
by: Hillary Claire Tunggal, et al.
Published: (2021-01-01)

Evaluation of a replication-competent VSV-SIV vaccine candidate
by: Jurgens CK, et al.
Published: (2012-09-01)

Antibodies in Vaccine Protection against SIV and HIV-1 Infection
by: Alpert, Michael
Published: (2012)

SIV replication in human cells
by: Hiroaki eTakeuchi, et al.
Published: (2012-04-01)

High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge.
by: Christopher T Campbell, et al.
Published: (2013-01-01)

Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation.
by: Katherine M Bricker, et al.
Published: (2020-10-01)

Vaccination and timing influence SIV immune escape viral dynamics in vivo.
by: Liyen Loh, et al.
Published: (2008-01-01)

The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template
by: Raiees Andrabi, et al.
Published: (2019-05-01)

Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
by: Berkower I, et al.
Published: (2012-09-01)

Investigation of immune responses induced by a mucosal SIV DNA vaccine
by: Brew, Robert
Published: (2002)

Accessory cell control of T lymphocyte function
by: Ibrahim, Mohammad Ahmad Abdallah
Published: (1993)

The Effect of Setting a Warning Vaccination Level on a Stochastic SIVS Model with Imperfect Vaccine
by: Maria Gamboa, et al.
Published: (2020-07-01)

Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques
by: Nichole R. Klatt, et al.
Published: (2021-03-01)

Correction: High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge
by: Christopher T. Campbell, et al.
Published: (2013-01-01)

Correction: High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge.
by: Christopher T. Campbell, et al.
Published: (2013-01-01)

Immune complexes can dampen inflammatory signaling at the mucosal surface during protective SIV vaccination
by: Smith AJ, et al.
Published: (2012-09-01)

Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
by: Fredrik Barrenäs, et al.
Published: (2021-07-01)

Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling
by: Jiabin Yan, et al.
Published: (2015-03-01)